BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23146500)

  • 21. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
    Panawong W; Chaiyakum A; Pongskul C
    J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
    Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
    Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of chronic allograft dysfunction by switch over to rapamycin.
    Sundaram V; Abraham G; Fathima N; Sundaram V; Reddy YN; Mathew M; Sathiah V
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):37-42. PubMed ID: 20061690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
    J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic renal disease in renal transplant patients: management of cardiovascular risk factors.
    Fernández-Fresnedo G; Gómez-Alamillo C; Ruiz JC; de Francisco AL; Arias M
    Transplant Proc; 2009 Jun; 41(5):1637-8. PubMed ID: 19545697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
    Shaheen FA; Kurpad R; Al-Sayyari AA; Souqiyyeh MZ; Aljubori H; El Baz T; Kashif W; Tuganbekova S; Kabulbayev K; Jarraya F; Nafar M
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):290-304. PubMed ID: 26997382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?
    Caldés Ruisánchez S; Marcén Letosa R; Amezquita Orjuela Y; Fernández Lucas M; Rivera Gorrin M; Galeano Álvarez C; Fernández Rodríguez A; Teruel Briones JL; Quereda Rodríguez-Navarro C
    Nefrologia; 2011; 31(1):51-7. PubMed ID: 21270913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD; Alvarez-Ude F; Gil MT; Moledous A; Malek T; Nuñez C; Devesa R; Carretón MA; Soriano A
    Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease.
    Portolés J; Castelao AM; Gorriz JL; Tato AM; de Alvaro F
    Ren Fail; 2009; 31(10):869-75. PubMed ID: 20030520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
    Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
    Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of living kidney donors over the past 28 years in a single center in Taiwan.
    Tsai SF; Shu KH; Ho HC; Wu MJ; Cheng CH; Lian JD; Wen MC; Su CK; Yu TM; Chuang YW; Huang ST; Chen CH
    Transplant Proc; 2012 Jan; 44(1):39-42. PubMed ID: 22310573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.
    Ibrahim S
    Hemodial Int; 2010 Jan; 14(1):61-7. PubMed ID: 19758297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.
    Bia M; Adey DB; Bloom RD; Chan L; Kulkarni S; Tomlanovich S
    Am J Kidney Dis; 2010 Aug; 56(2):189-218. PubMed ID: 20598411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination.
    Cataneo-Dávila A; Zúñiga-Varga J; Correa-Rotter R; Alberú J
    Transplant Proc; 2009 Dec; 41(10):4138-46. PubMed ID: 20005355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
    Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM
    Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.
    Marcén R; Galeano C; Fernandez-Rodriguez A; Jiménez S; Teruel JL; Burgos FJ; Quereda C
    Transplant Proc; 2012 Nov; 44(9):2593-5. PubMed ID: 23146465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional status and body composition in patients early after renal transplantation.
    Netto MC; Alves-Filho G; Mazzali M
    Transplant Proc; 2012 Oct; 44(8):2366-8. PubMed ID: 23026594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of native kidney function after pancreas transplantation alone.
    Le Dinh H; Deroover A; Coimbra C; Weekers L; Léonet J; Meurisse M; Squifflet JP
    Transplant Proc; 2012 Nov; 44(9):2829-33. PubMed ID: 23146535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.